Cargando…

Long non-coding RNAs in osteosarcoma

Long non-coding RNAs (lncRNAs) with more than 200 nuleotides, have been explored to participate in various cancer types including osteosarcoma (OS), which is the most common kind of primary bone tumors with high morbidity in infants and adolescents. These oncogenic or tumor suppressive lncRNAs regul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ruiling, Wang, Gangyang, Zheng, Ying, Hua, Yingqi, Cai, Zhengdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386777/ https://www.ncbi.nlm.nih.gov/pubmed/28103585 http://dx.doi.org/10.18632/oncotarget.14726

Ejemplares similares

Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies
por: Chen, Ruiling, et al.
Publicado: (2019)

Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications
por: Zheng, Ying, et al.
Publicado: (2018)

The Role of Long Non-Coding RNAs in Osteosarcoma
por: Smolle, Maria Anna, et al.
Publicado: (2018)

Immunogenic cell death in cancer therapy: Present and emerging inducers
por: Zhou, Jingyi, et al.
Publicado: (2019)

Research progress regarding the role of long non-coding RNAs in osteosarcoma
por: Zhang, Yanli, et al.
Publicado: (2020)

Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A
por: Wang, Zhuoying, et al.
Publicado: (2019)

Correlation between Patient‐Derived Xenograft Modeling and Prognosis in Osteosarcoma
por: Sun, Mengxiong, et al.
Publicado: (2022)

CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma
por: Wang, Zongyi, et al.
Publicado: (2019)

Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo
por: Wang, Gangyang, et al.
Publicado: (2022)

Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma
por: Rothzerg, Emel, et al.
Publicado: (2021)

Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma
por: He, Jieyu, et al.
Publicado: (2021)

NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy
por: Wang, Hongsheng, et al.
Publicado: (2017)

Long non-coding RNAs for osteosarcoma in the mouse: a meta-analysis
por: Hu, Shaopu, et al.
Publicado: (2017)

Integrative analysis reveals driver long non-coding RNAs in osteosarcoma
por: Luo, Zhenguo, et al.
Publicado: (2019)

Corrigendum: NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy
por: Wang, Hongsheng, et al.
Publicado: (2017)

Antitumor activity of Raddeanin A is mediated by Jun amino‐terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma
por: Wang, Zhuoying, et al.
Publicado: (2019)

Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case–control study
por: Zuo, Dongqing, et al.
Publicado: (2013)

Non-coding RNAs as potential biomarkers in osteosarcoma
por: Fan, Lijuan, et al.
Publicado: (2022)

Identification of pyroptosis-related genes and long non-coding RNAs signatures in osteosarcoma
por: Zhang, Jian, et al.
Publicado: (2022)

Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis
por: El Khodiry, Aya, et al.
Publicado: (2018)

Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs
por: Lulli, Matteo, et al.
Publicado: (2022)

Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients
por: Yang, Mengkai, et al.
Publicado: (2021)

On the classification of long non-coding RNAs
por: Ma, Lina, et al.
Publicado: (2013)

Long Non-coding RNAs in the Cytoplasm
por: Rashid, Farooq, et al.
Publicado: (2016)

Long Non-Coding RNAs in Insects
por: Choudhary, Chhavi, et al.
Publicado: (2021)

Long non-coding RNAs in ischemic stroke
por: Bao, Mei-Hua, et al.
Publicado: (2018)

Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis
por: Chen, Delong, et al.
Publicado: (2018)

Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications
por: Zhu, Tianyi, et al.
Publicado: (2022)

Long non-coding RNAs: From disease code to drug role
por: Chen, Yuanyuan, et al.
Publicado: (2021)

Long Non-Coding RNAs in Brown Adipose Tissue
por: Lai, Songjia, et al.
Publicado: (2020)

Primate-specific Long Non-coding RNAs and MicroRNAs
por: Awan, Hassaan Mehboob, et al.
Publicado: (2017)

Role of MicroRNAs and Long Non-Coding RNAs in Sarcopenia
por: Lee, Jihui, et al.
Publicado: (2022)

MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma
por: Detomas, Mario, et al.
Publicado: (2022)

Emerging roles of long non‐coding RNAs in neuropathic pain
por: Li, Zheng, et al.
Publicado: (2018)

Long non-coding RNAs in ovarian granulosa cells
por: Tu, Jiajie, et al.
Publicado: (2020)

Research Progress of Long Non-coding RNAs in Spinal Cord Injury
por: Cai, Zongyan, et al.
Publicado: (2022)

Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling
por: Jiang, Yafei, et al.
Publicado: (2021)

Long non-coding RNAs in anti-cancer drug resistance
por: Chen, Qin-nan, et al.
Publicado: (2016)

N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma
por: Yang, Kun, et al.
Publicado: (2022)

Involvement of long non‐coding RNAs in the progression of esophageal cancer
por: Xue, Wenhua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8q2civrphfkt63eljhusg26c9k